The role of hypogonadism correction in metabolic syndrome treatment in men: clinical case report
https://doi.org/10.14341/2071-8713-5317
Abstract
We report the clinical case which reflects the peculiarities of metabolic syndrome (MS) development in testosterone deficient state. Testosterone deficiency (hypogonadism) is likely to be one of the MS components in men. Clinical case presented demonstrates the pivotal role of complex pathogenetic approach to MS treatment in hypogonadal men. The only combination of diet, exercises and testosterone therapy is beneficial in MS treatment in hypogonadal men.
References
1. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results - Diabetes Voice Vol. 50 Issue 3: Sept 2005.
2. Hu et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004 May 24; 164(10): 1066-76., 2004.
3. Lakka H.M. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002 Dec 4; 288(21): 2709-16. Qiao Q.et al. DECODE Study Group. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006 Dec; 49(12): 2837-46.
4. Sundstrom J. et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006 Apr 15; 332(7546): 878-82.
5. Marin P., Arver S. Androgens and abdominal obesity. Baillieres Clin Endocrinol Metab. 1998 Oct; 12(3): 441-51.
6. Hu et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004 May 24; 164(10): 1066-76., 2004.
7. Laaksonen et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003 Dec; 149(6): 601-8. Armellini et al. Hormones and body composition in humans: clinical studies.Int J Obes Relat Metab Disord. 2000 Jun; 24 Suppl 2: S18-21.
8. Dobs et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. J Clin Endocrinol Metab. 2001 Mar; 86(3): 1026-33.
9. Tsai et al. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord. 2000 Apr; 24(4): 485-91.
10. Seidell J.C., Bjorntorp P., Sjostrom L., Kvist H., Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39(9): 897-901.
11. Khaw K.T., Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992 Sep; 2(5): 675-82.
12. Marin P., Oden B., Bjљrntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effect of androgen // J Clin Endocrinol Metab 1995; 80: 239-43.
13. Rebuffe-Scrive M., Marin P., Bjљrntorp P. Effect of testosterone on abdominal adipose tissue in men // Int J Obes Relat Metab Disord 1998; 83: 3277-84.
14. Heinemann L.A.J., Zimmermann T., Vermeulen A., Thiel C. A New 'Aging Male's Symptoms' (AMS) Rating Scale. The Aging Male 1999; 2:105-114.
15. Rhoden E.L. et al. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. International Journal of Impotence Research (2002) 14, 245-250.
Review
For citations:
, , , , , The role of hypogonadism correction in metabolic syndrome treatment in men: clinical case report. Obesity and metabolism. 2009;6(2):42-45. (In Russ.) https://doi.org/10.14341/2071-8713-5317
Views:
442
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
